Ascribe Bioscience Inc. has filed a notice of an exempt offering of securities to raise $15,272,656.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Ascribe Bioscience Inc. is raising up to $15,272,656.00 in new funding. The federal securities law requires the notice to be filed by companies that have…